Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1993 Nov;218(5):579–582. doi: 10.1097/00000658-199311000-00017

A current view of gastric cancer in the US.

W P Longmire Jr
PMCID: PMC1243027  PMID: 8239771

Abstract

In the US, the remarkable decline in the incidence of gastric cancer during the mid-portion of this century has leveled off during the last two decades as an equally remarkable and poorly understood increase in the percentage of the generally more unfavorable cardia cancers has become apparent. The importance of H. pylori infection is being actively investigated and treatment to reduce the infection may offer a means of decreasing the disease, particularly in areas of high incidence. The potential danger of inciting gastric cancer by the prolonged use of drugs that severely reduce or eliminate gastric acid has been mentioned, but the degree of risk must await the passage of years before it can be properly evaluated. "Early gastric cancer" or, probably more appropriately, "superficial gastric adenocarcinoma" continues to comprise a relatively small segment of gastric cancers in the US and most Western countries. Seventeen per cent of cases in the ACS series were classified as stage I, a much higher incidence than reported for early gastric cancer in most individual North American series. The ACS report suggests "special education of the surgeon in the requisites for adequate gastrectomy with node dissection, coupled with effective adjuvant therapy" as a means of improving results in the US. This is a significant consideration because, unfortunately, gastric surgery for ulcer or cancer no longer plays the important role it did in past decades in many US surgical training programs. As has been demonstrated in Japan and in certain larger US series, excellent surgical technique, particularly for cardia tumors, plays an important role in obtaining improved results. The value of radical lymph node dissection continues to be controversial in US cases, and a successful chemotherapeutic regimen has yet to be found. Subtotal gastric resection, as noted in the ACS report, continues to be the procedure of choice in the US for most gastric cancers, even for cardia cancers. Although there is no improvement in survival, quality of life is thought by some to be better after total gastrectomy for cardia cancers rather than proximal subtotal esophagogastrectomy. However, equally important for improved survival is the ACS recommendation of earlier referral for gastric surgery patients with precursor lesions, but the lack of improvement in the pathological stage of disease in the two ACS time periods suggests that little progress is being made in this country in this regard.

Full text

PDF
579

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Behrns K. E., Dalton R. R., van Heerden J. A., Sarr M. G. Extended lymph node dissection for gastric cancer. Is it of value? Surg Clin North Am. 1992 Apr;72(2):433–443. doi: 10.1016/s0039-6109(16)45688-4. [DOI] [PubMed] [Google Scholar]
  2. Blot W. J., Devesa S. S., Kneller R. W., Fraumeni J. F., Jr Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991 Mar 13;265(10):1287–1289. [PubMed] [Google Scholar]
  3. Buhl K., Schlag P., Herfarth C. Quality of life and functional results following different types of resection for gastric carcinoma. Eur J Surg Oncol. 1990 Aug;16(4):404–409. [PubMed] [Google Scholar]
  4. Cady B., Rossi R. L., Silverman M. L., Piccione W., Heck T. A. Gastric adenocarcinoma. A disease in transition. Arch Surg. 1989 Mar;124(3):303–308. doi: 10.1001/archsurg.1989.01410030049009. [DOI] [PubMed] [Google Scholar]
  5. Correa P. Clinical implications of recent developments in gastric cancer pathology and epidemiology. Semin Oncol. 1985 Mar;12(1):2–10. [PubMed] [Google Scholar]
  6. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992 Dec 15;52(24):6735–6740. [PubMed] [Google Scholar]
  7. Dooley C. P., Cohen H., Fitzgibbons P. L., Bauer M., Appleman M. D., Perez-Perez G. I., Blaser M. J. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 1989 Dec 7;321(23):1562–1566. doi: 10.1056/NEJM198912073212302. [DOI] [PubMed] [Google Scholar]
  8. Ellis F. H., Jr, Gibb S. P., Watkins E., Jr Limited esophagogastrectomy for carcinoma of the cardia. Indications, technique, and results. Ann Surg. 1988 Sep;208(3):354–361. doi: 10.1097/00000658-198809000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Farley D. R., Donohue J. H. Early gastric cancer. Surg Clin North Am. 1992 Apr;72(2):401–421. doi: 10.1016/s0039-6109(16)45686-0. [DOI] [PubMed] [Google Scholar]
  10. Forman D. Helicobacter pylori infection: a novel risk factor in the etiology of gastric cancer. J Natl Cancer Inst. 1991 Dec 4;83(23):1702–1703. doi: 10.1093/jnci/83.23.1702. [DOI] [PubMed] [Google Scholar]
  11. Forman D., Sitas F., Newell D. G., Stacey A. R., Boreham J., Peto R., Campbell T. C., Li J., Chen J. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer. 1990 Oct 15;46(4):608–611. doi: 10.1002/ijc.2910460410. [DOI] [PubMed] [Google Scholar]
  12. Golematis B., Tzardis P., Hatzikostas P., Papadimitriou K., Haritopoulos N. Changing pattern of distribution of carcinoma of the stomach. Br J Surg. 1990 Jan;77(1):63–64. doi: 10.1002/bjs.1800770123. [DOI] [PubMed] [Google Scholar]
  13. Marshall B. J., Warren J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984 Jun 16;1(8390):1311–1315. doi: 10.1016/s0140-6736(84)91816-6. [DOI] [PubMed] [Google Scholar]
  14. Papachristou D. N., Fortner J. G. Adenocarcinoma of the gastric cardia. The choice of gastrectomy. Ann Surg. 1980 Jul;192(1):58–64. doi: 10.1097/00000658-198007000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Parsonnet J., Friedman G. D., Vandersteen D. P., Chang Y., Vogelman J. H., Orentreich N., Sibley R. K. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991 Oct 17;325(16):1127–1131. doi: 10.1056/NEJM199110173251603. [DOI] [PubMed] [Google Scholar]
  16. Smith J. W., Brennan M. F. Surgical treatment of gastric cancer. Proximal, mid, and distal stomach. Surg Clin North Am. 1992 Apr;72(2):381–399. doi: 10.1016/s0039-6109(16)45685-9. [DOI] [PubMed] [Google Scholar]
  17. Smith J. W., Shiu M. H., Kelsey L., Brennan M. F. Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg. 1991 Dec;126(12):1469–1473. doi: 10.1001/archsurg.1991.01410360039007. [DOI] [PubMed] [Google Scholar]
  18. Soybel D. I., Modlin I. M. Sustained suppression of gastric secretion and the risk of neoplasia in the gastric mucosa. Am J Gastroenterol. 1991 Dec;86(12):1713–1719. [PubMed] [Google Scholar]
  19. Talley N. J., Zinsmeister A. R., Weaver A., DiMagno E. P., Carpenter H. A., Perez-Perez G. I., Blaser M. J. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst. 1991 Dec 4;83(23):1734–1739. doi: 10.1093/jnci/83.23.1734. [DOI] [PubMed] [Google Scholar]
  20. Wormsley K. G. Is chronic long-term inhibition of gastric secretion really dangerous? Scand J Gastroenterol Suppl. 1988;146:166–174. doi: 10.3109/00365528809099143. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES